Michael K. Keng, MD
PRIMARY APPOINTMENT:
Assistant Professor, Medicine: Hematology and Oncology
CONTACT:
UVA Emily Couric Clinical Cancer Center
1240 Lee St
Charlottesville, VA 22903
Telephone: 434.924.9333
Fax: 434.244.7526
Email: mk2pv@virginia.edu
EDUCATION AND TRAINING:
- Clinical Fellowship, Hematology-Oncology, Cleveland Clinic, Cleveland, Ohio
- MD, Michigan State University
- Residency, Internal Medicine, University of Southern California School of Medicine
RESEARCH INTERESTS:
Clinical trials in hematologic malignancies, including myelodysplastic syndromes and leukemias, with a special interest in treating the elderly population, determining optimal combinations and timing of targeted agents in MDS and leukemia, and studying patient safety and quality improvement.
RESEARCH SUMMARY:
Clinical trials in hematologic malignancies, including myelodysplastic syndromes and leukemias, with a special interest in treating the elderly population, determining optimal combinations and timing of targeted agents in MDS and leukemia, and studying patient safety and quality improvement.
SELECT PUBLICATIONS:
- Keng MK, Thallner EA, Elson P, Ajon C, Sekeres J, Wenzell CM, Seastone DJ, Gallagher EM, Weber CM, Earl MA, Mukherjee S, Pohlman B, Cober E, Foster VB, Yuhas J, Kalaycio ME, Bolwell BJ, Sekeres MA, Reducing Time to Antibiotic Administration for Febrile Neutropenia in the Emergency Department., 2015; Journal of oncology practice. 11(6) 450-5. PMID: 26220930
- Keng MK, Wenzell CM, Sekeres MA, A drug’s life: the pathway to drug approval., 2014; Clinical advances in hematology & oncology: H&O. 11(10) 646-55. PMID: 24518374
- Keng MK, Sekeres MA, Febrile neutropenia in hematologic malignancies., 2013; Current hematologic malignancy reports. 8(4) 370-8. PMID: 23990311